Source:http://linkedlifedata.com/resource/pubmed/id/16611329
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Pt 1
|
pubmed:dateCreated |
2006-4-13
|
pubmed:abstractText |
Inducing donor chimerism is the most consistently successful approach to achieve transplant tolerance. We found that a low level of donor chimerism, which was induced by a relatively non-toxic approach, induced donor-specific tolerance to islet allografts in chemically induced diabetic mice. However, a similar level of donor chimerism could not protect donor islet allografts in non-obese diabetic (NOD) mice that spontaneously developed autoimmune diabetes. Rejection of donor islet allografts in diabetic NOD mice with a low level of donor chimerism was mediated by recurrent autoimmunity. We used post-transplant donor lymphocyte infusion (DLI) to increase donor chimerism and to induce tolerance to islet allografts. DLI significantly increased donor chimerism and promoted donor-specific tolerance to islet allografts in diabetic NOD mice. Self-tolerance to islet autoantigens was restored and restoring self-tolerance is mediated by immunoregulation. Thus, our data showed that adoptive immunotherapy with post-transplant DLI after establishing a low level of donor chimerism as a platform enhances donor chimerism, induces donor-specific tolerance to islet allografts and restores self-tolerance in the setting of autoimmune diabetes. Our data also showed that central tolerance is not sufficient to induce tolerance and peripheral tolerance through immunoregulation for restoring self-tolerance is required in the setting of autoimmune diabetes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1600-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
933-46
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16611329-Adoptive Transfer,
pubmed-meshheading:16611329-Animals,
pubmed-meshheading:16611329-Blood Glucose,
pubmed-meshheading:16611329-Diabetes Mellitus, Type 1,
pubmed-meshheading:16611329-Graft Rejection,
pubmed-meshheading:16611329-Graft Survival,
pubmed-meshheading:16611329-Islets of Langerhans Transplantation,
pubmed-meshheading:16611329-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:16611329-Lymphocyte Transfusion,
pubmed-meshheading:16611329-Mice,
pubmed-meshheading:16611329-Mice, Inbred C57BL,
pubmed-meshheading:16611329-Mice, Inbred NOD,
pubmed-meshheading:16611329-Prediabetic State,
pubmed-meshheading:16611329-Transplantation, Homologous,
pubmed-meshheading:16611329-Transplantation Chimera,
pubmed-meshheading:16611329-Transplantation Tolerance
|
pubmed:year |
2006
|
pubmed:articleTitle |
Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion.
|
pubmed:affiliation |
Department of Surgery, Diabetes Institute for Immunology and Transplantation, University of Minnesota, Minneapolis, MN, USA, and Department of Surgery, Second Affiliated Hospital, China Medical University, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|